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Summary
The oncogenic epithelial–mesenchymal transition (EMT) contributes to tumor progression in various context-dependent ways, including
increased metastatic potential, expansion of cancer stem cell subpopulations, chemo-resistance and disease recurrence. One of the
hallmarks of EMT is resistance of tumor cells to anoikis. This resistance contributes to metastasis and is a defining property not only of
EMT but also of cancer stem cells. Here, we review the mechanistic coupling between EMT and resistance to anoikis. The discussion
focuses on several key aspects. First, we provide an update on new pathways that lead from the loss of E-cadherin to anoikis resistance.
We then discuss the relevance of transcription factors that are crucial in wound healing in the context of oncogenic EMT. Next, we
explore the consequences of the breakdown of cell-polarity complexes upon anoikis sensitivity, through the Hippo, Wnt and
transforming growth factor b (TGF-b) pathways, emphasizing points of crossregulation. Finally, we summarize the direct regulation of
cell survival genes through EMT-inducing transcription factors, and the roles of the tyrosine kinases focal adhesion kinase (FAK) and
TrkB neurotrophin receptor in EMT-related regulation of anoikis. Emerging from these studies are unifying principles that will lead to
improvements in cancer therapy by reprogramming sensitivity of anoikis.
Key words: EMT, Anoikis, Cancer
Introduction
Epithelial tissues with a high turnover, for example, in the
gastrointestinal tract and skin, shed billions of epithelial cells per
minute. Intuitively, there is a need for cells that are shed in this
manner to be eliminated as, otherwise, we would be in constant
danger that they attach at inappropriate sites, leading to
widespread neoplastic growth. This problem would be
exacerbated by precancerous mutations or epigenetic changes
that occurred in the epithelial cells prior to shedding.
About eighteen years ago, two publications showed that
epithelial cells and endothelial cells depend on appropriate cell–
matrix interactions for their survival, confirming this intuition
(Frisch and Francis, 1994; Meredith et al., 1993). The
transformation of epithelial cells by oncogenes was further
shown to confer resistance to the apoptosis phenomenon termed
anoikis, which occurs when cells lost contact with their
extracellular matrix. This definition of anoikis was later
broadened to include any apoptosis that is inhibited by
appropriate cell–matrix interactions. Intriguingly, a ubiquitously
acting tumor suppressor, adenovirus E1a, was shown to restore
sensitivity to anoikis (Frisch and Francis, 1994).
Further extension and refinement of research since then has
demonstrated that, in the context of cancer, resistance to anoikis,
a hallmark of the oncogenic epithelial–mesenchymal transition
(EMT), is required for tumor metastasis (Guadamillas et al.,
2011; Tiwari et al., 2012). The mechanistic connections between
EMT and anoikis resistance are the focus of this Commentary.
Here, we address the specific question that is posed in Fig. 1:
how does the oncogenic EMT confer resistance to anoikis, and
can this be exploited to develop novel modalities for cancer
therapy? We focus on the interactions between various signaling
pathways that regulate the cellular commitment to EMT, in turn
modulating cell-survival-related gene expression programs that
adjust the setpoint for anoikis.
EMT
The defining characteristic of epithelial cells is their propensity to
exist as a layer of extensively communicating cells, which
manifests itself as the familiar cobblestone pattern that can be
seen in two-dimensional cell culture. Specific epithelial proteins
such as E-cadherin, occludins, claudins, desmogleins and
desmocollins are located at cellular junctions, which promote
and maintain the integrity of epithelial layers (Baum and
Georgiou, 2011; Dusek and Attardi, 2011; Turksen and Troy,
2011). In vivo epithelial cells are typically polarized with one
side attached to extracellular matrix and adjacent cells, and the
other facing the lumen of a vessel. Maintenance of the polarity is
achieved by the tight junctions through claudins and occludins,
which prevent integral membrane proteins from diffusing
between the apical and basolateral membranes (Yeaman et al.,
1999). The appropriate localization of these junctional proteins in
epithelia is regulated by epithelial-specific cytosolic proteins,
such as ankyrin G and Rab25 (Kizhatil et al., 2007a; Kizhatil
et al., 2007b; Senga et al., 2012). The master regulators of the
epithelial gene expression program have recently been identified;
among these are the transcription factors grainyhead-like protein
2 homolog (GRHL2) and GATA3, the mRNA splicing factors
ESRP1 and ESRP2, and the mir200 family of micro-RNAs
(Cieply et al., 2012; Gregory et al., 2008; Kouros-Mehr et al.,
2008; Warzecha et al., 2010; Werth et al., 2010).
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Separation of a normal epithelial cell from its matrix results in
anoikis. Epithelial cells can be re-programmed, however, so that
they no longer require these attachments for their survival,
through a process known as EMT. The defining characteristics
of EMT in culture are (i) deviation from the cobblestone
morphology, owing to loss of cell adhesion molecules such as E-
cadherin; (ii) loss of epithelium-specific genes; (iii) gain of
mesenchymum-specific genes and (iv) loss of sensitivity to
anoikis (Kalluri and Weinberg, 2009; Scheel and Weinberg,
2011; Tiwari et al., 2012). Enhanced migratory capacity of cells
is commonly used as a marker of EMT; however this feature is
context-dependent as epithelial sheets can migrate as well or
better than individual mesenchymal cells (Matise et al., 2012).
EMT is observed in vivo during the delamination of the neural
crest or in the invasive front of carcinoma, which are both
examples of cells that detach from their epithelial layer and
migrate (Brabletz et al., 2001; Theveneau and Mayor, 2012). The
factors and microenvironmental cues that regulate EMT, and its
significance to development and disease have been reviewed
extensively elsewhere (Guarino et al., 2007; Kalluri and
Weinberg, 2009; Klymkowsky and Savagner, 2009; Thiery
et al., 2009; Weinberg, 2008). Here, we focus on the gene
expression and cell signaling events that are associated with EMT
and that contribute to anoikis resistance.
Anoikis
The term anoikis is used to distinguish a scenario of apoptosis –
for example, the response to cell–matrix detachment – not a
mechanism. In fact, many of the apoptotic mechanisms that occur
in response to other cellular stresses apply to anoikis, as noted
below. Subsequently, we discuss upstream regulators of the
apoptotic machinery that are likely to be unique to anoikis.
In anoikis, the ubiquitous regulatory proteins of the Bcl-2
family control mitochondrial outer-membrane permeabilization,
cytochrome c release and apoptosome assembly just as they do in
other apoptotic scenarios. Specific roles for the upregulation of
the pro-apoptotic BH3-only protein Bim in detached cells of the
mammary epithelial cell line MCF10a, or degradation of the anti-
apoptotic protein Mcl1 in detached 3T3 cells has been noted
(Reginato et al., 2003; Woods et al., 2007).
Activation of the phosphoinositide 3-kinase (PI3K)/Akt
pathway has a widespread role in cell survival signaling in
general, and anoikis is no exception. Accordingly, activation of
insulin receptor or insulin-like growth factor receptors upstream
of PI3K/Akt is important in the resistance of tumor cells to
anoikis (Martin et al., 2006). A clinically important connection
between anoikis and systemic metabolic changes in response to
diet, exercise and growth hormones is implied by this
observation, and warrants further investigation.
Cellular metabolic regulation of the levels of crucial energy
carriers – such as nicotinamide adenine dinucleotide phosphate
(NADP+) or its reduced form NADPH and ATP, and that of
reactive oxygen species (ROS) is also an important feature in the
regulation of cell survival. Correspondingly, integrin signaling
partly regulates anoikis by controlling the pentose phosphate
pathway and, specifically, NADPH and ROS (Schafer et al.,
2009). Interestingly, this work sounds a cautionary note because
antioxidants that are considered as chemopreventive agents might
inhibit anoikis, thus acting as tumor promoters.
In addition to these factors, other components of the core
apoptotic machinery (e.g. death receptors) have also been
implicated in anoikis. For example, The FAS-associated death
domain protein (FADD) has been shown to contribute to anoikis
through unknown mechanisms, suggesting a potential role for
death receptors in the process (Frisch, 1999). Nevertheless, a role
for death receptors in anoikis has been shown only in certain cell
lines, or following experimental manipulations that are only
remotely related to anoikis, raising questions about the generality
of this role.
As a general mediator of stress- and genotoxin-induced
apoptosis, p53 might intuitively be expected to promote
anoikis. However, this has so far been shown only in a limited
context, i.e. in specific cell lines with PI3K-activating mutations,
in which salt-inducible kinase 1 (SIK1) regulates anoikis through
p53 (Cheng et al., 2009). A more general role of p53 in anoikis
has not been shown. However, a protective role of the p53-related
protein p63 (Tp63) through induction of extracellular matrix and
integrin gene expression has been demonstrated (Carroll et al.,
2006).
The role of E-cadherin in anoikis
The publication that first described anoikis reported that Madin-
Darby canine kidney epithelial cells (MDCK) show an increased
sensitivity to anoikis when they are grown to confluence (Frisch
and Francis, 1994). The exact basis for this phenomenon in
MDCK is still not fully elucidated and may be due to multiple
factors. Two studies strongly support the contention that E-
cadherin-mediated cell interactions have a significant role in
sensitizing epithelial cells to anoikis. The conditional knockout of
E-cadherin in a p53-dominant-negative tumor cell model
enhances tumor metastasis substantially and the derived
cultured cells are highly resistant to anoikis compared with E-
cadherin-expressing control cells (Derksen et al., 2006). A
subsequent, more mechanistic, study reported similar findings by
using the immortalized human mammary epithelial (HMLE) cell
line (Onder et al., 2008). Here, stable knockdown of E-cadherin
confers anoikis resistance to the cells that is accompanied by
EMT. This effect has been attributed to the decreased
Cell shedding
Anoikis
Cell shedding
Metastasis
Normal cells Tumor cells
Fig. 1. EMT programs anoikis resistance. Mechanisms that connect these
phenomena are discussed in this Commentary. The intercellular bridge
protein depicted in this diagram is a generalized intercellular component of
junctional complexes (e.g. E-cadherin, desmoplakin, desmoglein, claudin)
and a generalized cytoplasmic or cytoskeletal element is shown transducing
its signals.
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phosphorylation of b-catenin and, therefore, its increased
activation, resulting in Wnt activation (Onder et al., 2008).
Consistent with this, anoikis sensitivity can be partially restored
by simultaneous knockdown of b-catenin. Total b-catenin levels
were not, however, affected, and although there is clear evidence
for activation of the Wnt pathway, this work could not exclude
the existence of additional pathways that link E-cadherin to
anoikis resistance.
Subsequently, an additional pathway was found, that involved
an unexpected factor ankyrin-G (Kumar et al., 2011). Ankyrin-G
is the widely expressed epithelial isoform of the ankyrin family
of cytoskeletal linker proteins. Ankyrin-G bridges the
cytoskeleton, through spectrin and actin complexes, with the
cell membrane, through diverse transmembrane proteins
including CD44, Na+/K+-ATPase, L1CAM and, importantly, E-
cadherin (Bennett and Healy, 2008; Kizhatil et al., 2007a). In
addition, ankyrin-G is downregulated in diverse types of tumor,
and is included in a signature – consisting of eleven genes – that
correlates with poor prognosis following chemotherapy of cancer
patients (Glinsky et al., 2005). Moreover, ankyrin-G has two
domains that are implicated in apoptosis: a death domain and a
ZU5 domain. Together, they comprise a ‘supermodule’ of a
defined structure that is also present in the apoptosis-regulating
netrin receptor Unc5 (Wang et al., 2009). The ZU5 domain of
ankyrin-G, similar to that of Unc5, has been found to interact
with the neurotrophin-receptor-associated MAGE homolog
(MAGED1, also known as and hereafter referred to as
NRAGE), a member of the melanoma antigen family of
proteins that has been previously shown to regulate apoptosis
in conjunction with Unc5 (Williams et al., 2003). Ankyrin-G has
been shown to sequester NRAGE in the cytoplasm (Kumar et al.
2011). In the absence of ankyrin-G (e.g. after the loss of E-
cadherin accompanying EMT), a fraction of NRAGE translocates
to the nucleus, where it interacts with the oncogenic
transcriptional repressor protein TBX2, forming a repressor/co-
repressor complex that attenuates the gene expression of the
tumor suppressor p14ARF (CDKN2A) (Kumar et al., 2011). In
HMLE cells, p14ARF promotes anoikis (Kumar et al., 2011).
Consequently, the repression of p14ARF confers anoikis
resistance, suggesting a novel pathway that regulates anoikis
through E-cadherin–ankyrin-G complexes (Kumar et al., 2011),
as depicted in Fig. 2.
It is worth noting that MCF10a cells, which are widely used to
study anoikis, do not express p14ARF. Anoikis occurs far more
slowly in this cell line, compared with other mammary epithelial
cell lines (,48 hours for commonly used MCF10a variants,
versus 4–6 hours for HMLE cells, to reach a threshold where cell
death can be detected by a DNA-fragmentation assay), and the
ectopic expression of low levels of p14ARF dramatically
sensitizes these cells to anoikis. This observation, and the
correlation between the expression of ankyrin-G and p14ARF in
breast cancer cell lines, suggests that p14ARF is an important
determinant of anoikis sensitivity (Kumar et al., 2011). This may
also constitute an underlying reason for the widespread loss of
p14ARF in human cancers and the observation that even
heterozygosity for wild-type p14ARF correlates strongly with
tumor incidence (Hewitt et al., 2002; Moreno-Miralles et al.,
2005). Although p14ARF was originally shown to induce
apoptosis through p53, p53-independent mechanisms that
involve its interaction with the Myc proto-oncogene, the
generalized EMT-mediating co-repressor protein, C-terminal
binding protein (CTBP) or the mitochondrial p32 protein have
now been shown (Itahana and Zhang, 2008; Paliwal et al., 2006;
Qi et al., 2004).
Another suggestion arising from this report is that the
downregulation of ankyrin-G is so prevalent that it could be
considered as a marker for EMT (Kumar et al., 2011). However,
it cannot be excluded that ankyrin-G regulates anoikis through
additional mechanism that are mediated by its death domain and/
or the solenoid conformation of the ankyrin-repeat domain,
which has been shown to act as a mechanotransducer (Lee et al.,
2006).
In addition, another pathway linking E-cadherin to the control
of anoikis is emerging. Homophilic interactions between E-
cadherins of neighbouring cells is an important initiator of
contact inhibition, and this effect was shown to involve the
regulation of phosphorylation of Yes-associated protein (YAP), a
key component of the Hippo signaling pathway. The role of the
Hippo pathway in anoikis has been further demonstrated more
recently (discussed below), indicating that E-cadherin is likely to
control anoikis through this additional pathway.
Taken together, the regulation of anoikis by E-cadherin is
surprisingly complex, involving at least three pathways: Wnt –
through b-catenin and T-cell-specific transcription factors
(TCFs), the ankyrin–NRAGE–TBX2–p14ARF signaling axis,
and the Hippo pathway, with others probably still awaiting
discovery. In addition, these pathways are also likely to interact,
as discussed below.
The role of cell polarity in anoikis
Epithelial cell polarity is compromised during oncogenic EMT
through diverse transcriptional and signaling effects (Godde et al.,
2010; Moreno-Bueno et al., 2008; Xu et al., 2009). Three polarity
complexes, crumbs, Par and scribble, contribute to polarity in
normal epithelial cells and aberrations in each of these affect
tumor progression (Ellenbroek et al., 2012). Below, we discuss
the demonstrated or inferred roles of these complexes in the
regulation of anoikis.
As a preface to this, it is important to understand that those
signaling pathways that are crucial for EMT, i.e. the Hippo
E-cadherinNRAGE
ankyrin-G
TBX2 CDKN2A
Anoikis
sensitive
NRAGE
TBX2
Anoikis
resistant
NRAGE
X
EMT
Pre-EMT Post-EMT 
Fig. 2. E-cadherin and ankyrin-G are lost coordinately during EMT,
conferring anoikis resistance. This occurs because the ankyrin-G-interacting
protein NRAGE is no longer sequestered by ankyrin-G. This, in turn, permits
translocation of NRAGE to the nucleus, where it forms a repressor/co-
repressor complex with TBX2, thereby blocking the expression of the
p14ARF gene (CDKN2A) and attenuating anoikis.
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pathway, the transforming growth factor b (TGF-b) pathway and
the Wnt pathway, are highly interconnected and that there is a
substantial degree of cross-talk between them (see recent review
by Varelas and Wrana, 2012). TGF-b and Wnt signaling induce
EMT in a cooperative manner and drive anoikis resistance
(Gauger et al., 2011; Scheel et al., 2011), whereas Hippo
signaling has been viewed as the conductor that orchestrates the
TGF-b–Wnt ‘symphony’ (Varelas and Wrana, 2012).
Further insights into the role of Hippo signaling in anoikis
have emerged recently from two studies. First, the p53 effector
protein ASPP1 (also known as PPP1R13B) was found to activate
the two principal transcriptional co-activator proteins of the
Hippo pathway, YAP and TAZ, by inhibiting their interaction
with the inactivating kinases LATS1 or LATS2, which normally
leads to nuclear export and degradation of YAP and TAZ (Fig. 3)
(Vigneron et al., 2010). Directly or indirectly, activation of YAP
and TAZ results in the downregulation of the pro-apoptotic
protein Bim (also known as BCL2L11), thus protecting cells
against anoikis. This result indicates a novel role for ASPP1 as a
potentially oncogenic promoter of cell survival, although it also
raises the question of how the transcriptional co-activators YAP
and TAZ repress Bim gene expression.
A recent report demonstrates that YAP phosphorylation is
regulated by integrin–matrix interactions in a manner that is
dependent on the actin and tubulin cytoskeleton (Zhao et al.,
2012a). The authors show that cell–matrix detachment activates
LATS1 and LATS2, thereby inactivating YAP. The functional roles
of these factors were demonstrated by manipulating their expression
in normal or tumor cell lines, and the observation that LATS1 and
LATS2 are downregulated in metastatic prostate tumors.
The above findings suggest a function for Hippo in anoikis and
are complemented by other work that links Hippo signaling to
cell polarity proteins. For instance, pronephros development in
zebrafish is controlled in part by the interaction between the
cadherin family member Fat1, which is an upstream component
of the Hippo pathway, and scribble. The resulting phenotype
(cyst formation) is also affected by mutations in YAP,
underscoring the importance of interactions between the Hippo
and the cell polarity pathways (Skouloudaki et al., 2009).
In mammalian epithelial cells, YAP and TAZ also interact
with scribble or crumbs (Varelas and Wrana, 2012). In their
unphosphorylated forms, YAP and TAZ are localized in the
nucleus, where they interact with Smad complexes (transducers
of TGF-b signaling) to promote the nuclear localization of Smad
and the activation of its target genes. Upon activation of the
Hippo pathway, kinases LATS1 and LATS2, and YAP and TAZ
are phosphorylated and excluded from the nucleus, so that they
can interact with cell polarity proteins – such as membrane-
localized scribble and crumbs, which stably sequester YAP and
TAZ to the membrane (Varelas and Wrana, 2012).
During EMT, polarity proteins fail to localize correctly to the
membrane, relieving the sequestration of Smads and promoting
C
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Silent YAP, TAZ, SMAD3 and
β-catenin target genes
Anoikis-sensitive
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Epithelial-specific
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Active YAP, TAZ, SMAD3 and
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Fig. 3. The epithelial specific cell polarity proteins and maintain anoikis sensitivity by regulating the Hippo, Wnt and TGF-b pathways. In normal,
interacting epithelial cells (left panel), the cell polarity complexes, crumbs (Crb) and scribble (Scrib) stimulate the phosphorylation of YAP and TAZ through the
LATS kinase. This maintains YAP and TAZ in the cytoplasm, sensitizing cells to anoikis. In addition, cytoplasmic YAP and TAZ interact with Smad3 and prevent
its nuclear translocation, even in the presence of active TGF-b receptors. Furthermore, cytoplasmic TAZ interacts with disheveled (Dsh), inhibiting canonical Wnt
signaling. Expression or activation of CTBP; ZEB1/2,Snail, Twist, FAK, ILK, NF-kB or TrkB induce EMT (right panel), which – in turn – compromises cell
polarity complexes, promotes the nuclear translocation of YAP, TAZ and Smad3, and induces expression of cell survival genes. The absence of cytoplasmic TAZ
allows Dsh to be activated by CK1, which inhibits glycogen synthase kinase 3 b (GSK3b), thus allowing b-catenin to transactivate pro-survival genes in the
nucleus. Alternatively, the Akt–GSK3b–b-catenin axis can be stimulated through activation of TrkB.
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TGF-b signaling, which, in turn, stabilizes the EMT phenotype
and the consequent resistance to anoikis (Humbert et al., 2008;
Varelas et al., 2010b) (Fig. 3). An example of this is the
inhibitory interaction between the crumbs polarity complex and
Smads that is mediated by YAP and TAZ. The phosphorylated
forms of YAP and TAZ interact with crumbs, thereby
sequestering Smads and inhibiting both pathways (Varelas et al.,
2010b). Although not yet tested directly, this is predicted to
maintain anoikis sensitivity in normal epithelial cells, as the role
of YAP and TAZ and that of TGF-b signaling in anoikis is
established (Cieply et al., 2012; Zhao et al., 2012a).
Another example of the interplay between the cell polarity
pathways is the interaction between the cell polarity protein
scribble and the Hippo pathway co-activator TAZ (also known as
WWTR1), which, in its phosphorylated form, is found in the
cytoplasm (Cordenonsi et al., 2011). TAZ activity correlates with
a cancer stem cell phenotype in mammary tumors, as reflected by
the expression profile of TAZ target genes, and is functionally
important for maintaining this phenotype in cell culture models
(Cordenonsi et al., 2011). Manipulating TAZ gene expression
does not affect EMT, but is required for mammosphere
generation, which is a marker of cancer stem cells that clearly
requires a transition to anoikis resistance. Scribble is frequently
defective in tumor cells and, following EMT, is aberrantly
localized to the cytoplasm instead of at the basolateral membrane
(Humbert et al., 2008). Interestingly, scribble normally inhibits
TAZ activation in epithelial cells, which has been attributed to its
role in promoting an inhibitory LATS1–TAZ complex, but when
it is mislocalized in cells with a mesenchymal phenotype, it is
unable to inhibit TAZ by this means, resulting in hyperactive
TAZ and promoting the anoikis resistance that facilitates
mammosphere formation (Cordenonsi et al., 2011).
Interestingly, YAP and TAZ interact also with the disheveled
homolog Dvl, inhibit its activation through casein kinase I (CK1),
and the subsequent activation of the canonical Wnt pathway,
which is crucial in the control of anoikis (Onder et al., 2008;
Varelas et al., 2010a). This observation provides a mechanism by
which cell polarity complexes might regulate anoikis through a
YAP(TAZ)–Dvl-Wnt axis (Fig. 3).
It should be emphasized that different polarity complexes
may have distinct, cell-type specific roles. For example, in a
keratinocyte cell line (HaCat), depletion of scribble compromises
cell–cell adhesion and increases matrigel invasiveness, without
having a significant effect on anoikis. By contrast, the depletion
of the discs large homologue 1 (Dlg1) in these cells maintains
cell-cell adhesion and suppresses invasiveness, but profoundly
decreases the occurrence of anoikis (Massimi et al., 2012). Thus,
specific molecular components of polarity complexes may
regulate anoikis in certain instances instead of cell polarity per se.
Finally, several lines of evidence point to a role of Jun N-
terminal kinase (JNK) signaling as another possible link between
cell polarity and anoikis. First, anoikis and cell polarity in three-
dimensional MCF10a acinar cultures both depend on JNK
signaling (McNally et al., 2011). Second, the mammary-gland-
specific knockout of JNK1 and JNK2 (MAPK8 and MAPK9,
respectively) demonstrates that they have tumor-suppressive
activities that are accompanied by defective luminal clearing, a
sign of defective anoikis (Cellurale et al., 2010). From the cell
polarity perspective, scribble enforces anoikis-driven luminal
clearing in MCF10a acini through Rac–JNK signaling (Zhan
et al., 2008). Although JNK is a clear candidate for linking
polarity with anoikis, it is almost certain that there are also other
signals that yet await discovery.
In summary, cell polarity-determining adhesion molecules are
frequently downregulated by transcription factors that meditate
EMT. In turn, the loss of correctly localized cell-polarity
complexes alters signaling through Wnt, TGF-b and Hippo
signaling pathways and, thus, reinforces the EMT phenotype and
enables tumor cells to evade anoikis.
Control of cell survival genes by EMT transcription factors
As mentioned earlier, anoikis utilizes the canonical apoptotic
machinery, including Bcl-2 family members, caspases and,
perhaps, death receptor signaling components. In this section,
we describe the gene regulation of these proteins by transcription
factors that drive EMT.
The E-box-binding factors Snail, Slug, Twist and zinc finger
E-box-binding homeoboxes 1 and 2 (ZEB1 and ZEB2,
respectively) were originally characterized as transcriptional
repressors of cell adhesion genes that encode components of
adherens junctions, desmosomes and tight junctions (Thiery et al.,
2009; Tiwari et al., 2012). By downregulating junctional
assembly, they interfere with cell polarity and may suppress
anoikis through the pathways described above. Additionally,
these factors can control cell survival genes. For example, ZEB1
represses the pro-apoptotic tumor protein p73 (Tp73) gene
through direct interaction with the E-box sites that are present
in intron 1 (Fontemaggi et al., 2001). Other apoptosis-regulating
target genes for ZEB1 and Snail have been proposed (Sayan et al.,
2009; Wu and Zhou, 2010). Apoptosis induced by Myc is
dependent upon induction of p14ARF gene expression, which
results in the highly pro-apoptotic Myc–ARF complex (Qi et al.,
2004). Twist directly represses the expression of the p14ARF
gene, thereby suppressing apoptosis by blocking the formation of
this complex and collaborating with Myc to transform cells
(Valsesia-Wittmann et al., 2004). It is noteworthy that Myc
promotes apoptosis during luminal clearing in MCF10a acinar
development and, thus, might also contribute to anoikis (our own
unpublished data), providing a molecular pathway by which
Twist might suppress anoikis (Zhan et al., 2008).
NF-kB is crucial for the induction of EMT in some contexts,
which provides interesting conceptual links of EMT and anoikis
to inflammatory cytokines (Li et al., 2012; Min et al., 2008;
Pantuck et al., 2010). Several studies have demonstrated a
significant role for NF-kB in anoikis, particularly in intestinal
epithelial cells (Toruner et al., 2006; Yan et al., 2005). NF-kB is
also important in cell survival signaling by activating its target
genes, which include two members of the inhibitor of apoptosis
(IAP) family, survivin and XIAP, as well as CFLAR, bcl-xl
(BCL2L1), bcl-2 (BCL2) and osteoprotegerin (TNFRSF11B).
Other targets are cytokine genes such as tumor necrosis factor
(TNF) and interleukin-6 (IL6) that participate in a positive
feedback loop to further activate NF-kB. In this context, survivin
has recently shown to have a crucial role in regulating anoikis: a
complex containing survivin and XIAP activates NF-kB, which
leads to an increased expression of fibronectin, that, in turn,
establishes integrin clustering under detached conditions and
results in rescue from anoikis (Mehrotra et al., 2010). This study
clearly illustrates the concept that increased expression of matrix
proteins during EMT is a mechanism underlying anoikis-rescue
through constitutive integrin clustering, which has also been
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proposed for certain mammary epithelial cells (Zahir et al., 2003)
and might also apply more generally.
Finally, the transcriptional co-repressor CTBP is also required
for most, if not all, cases of EMT and it attenuates anoikis
(Grooteclaes et al., 2003); it might act with ZEB1 to repress gene
expression of E-cadherin and other epithelial genes (Grooteclaes
and Frisch, 2000). Interestingly, CTBP also represses the
promoter of Bcl-2-interacting killer (Bik), a member of the
BH3 family of pro-apoptotic genes, a function that is antagonized
by the alternative reading frame (ARF) tumor suppressor, which
normally promotes anoikis (Kovi et al., 2010; Kumar et al.,
2011). Conversely, the wound-healing regulatory transcription
factor GRHL2 has recently been found to suppress EMT, in part,
by repressing ZEB1 expression and TGF-b transcriptional
signaling. Accordingly, GRHL2 restores sensitivity of tumor
cells to anoikis and attenuates two cancer stem cell phenotypes,
mammosphere generation and CD44 expression (Cieply et al.,
2012). However, for both CTBP and GRHL2, the mechanisms
that link EMT to anoikis resistance have yet to be determined.
The expression of phosphatase and tensin homolog (PTEN), an
antagonist of Akt signaling, is repressed by CTBP and activated
by GRHL3 (a protein highly related to GRHL2 both structurally
and functionally) and PTEN could, thus, be an important
interface between EMT and anoikis (Darido et al., 2011;
Paliwal et al., 2007).
The role of FAK and ILK in coupling anoikis resistance
with EMT
The roles of focal adhesion kinase (FAK) and integrin-linked
protein kinase (ILK) in suppressing anoikis are well established
(Atwell et al., 2000; Frisch et al., 1996). FAK and ILK colocalize
with integrins at sites of cell attachment to the extracellular
matrix, and integrin-ligand interactions stimulate the function of
these proteins (Hannigan et al., 1996; Lipfert et al., 1992;
Schaller et al., 1992). Attachment of epithelial cells to collagen I
can induce EMT, and both FAK and ILK have been implicated in
the control of EMT in response to adhesion to collagen I (Medici
and Nawshad, 2010; Shintani et al., 2008). FAK and ILK are also
activated in response to growth factors, including ligands of
growth factor receptors that induce EMT, and they have been
implicated in the control of growth-factor-induced EMT, for
example in response to TGF-b (Cicchini et al., 2008; Serrano
et al., 2013). Conventionally, FAK activates PI3K and mitogen-
activated protein kinase (MAPK). These pathways stimulate the
Ets and SP1 transcription factors (Wang et al., 2008). FAK-
mediated increase in SP1 activity directly results in an elevated
expression of another transcription factor, Kru¨ppel-like factor 8
(KLF8) (Wang et al., 2008; Zhao et al., 2003), which is a driver
of EMT under some conditions (Wang et al., 2007). Ectopic
expression of KLF8 represses the expression of E-cadherin by
directly binding to a GT-box in the E-cadherin promoter (Wang
et al., 2007). Thus, one potential signaling pathway through
which FAK might drive EMT is the FAK–PI3K–MAPK–SP1–
KLF8 axis; however, this hypothesis has not yet been firmly
established. FAK has also been implicated in regulating the gene
expression of Snail, Zeb1, Zeb2 and Twist in fibroblasts (Li et al.,
2011), which requires activity of MAPK and PI3K. Moreover,
expression of these transcription factors is also crucial to
maintain the mesenchymal phenotype of murine fibroblasts,
including suppression of E-cadherin gene expression (Li et al.,
2011). Although FAK is involved in regulating the expression of
the E-cadherin gene under some conditions, in other models
of EMT FAK does not have a role in regulating the expression of
epithelial markers, including that of the E-cadherin gene, but has
been implicated in inducing the expression of mesenchymal
genes (Cicchini et al., 2008). FAK also has a role in regulating
the surface expression of E-cadherin, as impairment of FAK
attenuates internalization of E-cadherin upon EMT induction
(Cicchini et al., 2008). Furthermore, impaired E-cadherin
internalization can be seen when FAK is inhibited in a mouse
model (Canel et al., 2010), but the underlying mechanism
remains to be determined.
Ectopic expression of ILK in lung cancer cells promotes
morphological changes that are associated with EMT, such as
downregulation of the E-cadherin gene and elevated expression
of mesenchymal genes (Chen et al., 2013). Conversely, inhibition
of ILK expression in bladder carcinoma cells, breast cancer cell
lines and TGF-b stimulated mammary epithelial cells impairs the
gene expression of mesenchymal markers and results in elevated
expression of the E-cadherin gene (Serrano et al., 2013; Zhu et al.,
2012). Mesenchymal markers that are regulated by ILK include
the transcription factors Snail and Slug (Chen et al., 2013; Medici
and Nawshad, 2010; Serrano et al., 2013; Zhu et al., 2012). These
results may be clinically relevant, as elevated protein expression
of ILK correlates with increased gene expression of Snail and
decreased expression of the E-cadherin gene in oral squamous
cell carcinoma tumor samples (Zhao et al., 2012b), examples of
transcriptional regulation that are thought to be mediated by the
regulation of NF-kB activity through ILK (Chen et al., 2013;
Medici and Nawshad, 2010).
The role of TrkB in anoikis and EMT
Originally isolated as an oncogenic fusion protein (Martin-Zanca
et al., 1986), tropomyosin-related kinase A (Trk, also known as
NTRK1) is the founding member of a family of proteins that have
a crucial role in the nervous system. Acquired expression of some
Trk family members (TrkA and TrkC) in various types of cancer
can be a good prognostic indicator (Thiele et al., 2009). However,
acquired expression of TrkB (NTRK2) has been associated with
poor patient survival (Thiele et al., 2009). TrkB contributes to
disease progression by inhibiting anoikis and promoting EMT. A
role of TrkB in preventing anoikis emerged from an unbiased
screen of rat intestinal epithelial (RIE) cells for genes that are
capable of suppressing anoikis (Douma et al., 2004). Stimulation
with brain-derived neurotrophic factor (BDNF), a natural ligand
for TrkB, enhances TrkB-mediated cell survival. The kinase
activity of TrkB is essential for protection against anoikis, and
PI3K appears to be an important downstream target of this cell-
survival pathway (Douma et al., 2004; Geiger and Peeper, 2007).
Expression of TrkB in several epithelial cell lines induces a
profound morphological change. Although the details vary
depending on which cell line is used, expression of epithelial
markers is always reduced, whereas that of mesenchymal
markers is always enhanced (Smit et al., 2009).
Pharmacological studies suggest that MAPK, but not PI3K, is
crucial for the observed changes in morphology and alterations in
the expression of EMT markers. Three EMT-associated
transcription factors, Twist, Snail and ZEB1 are essential for
TrkB-induced EMT and downregulation of E-cadherin gene
expression is also crucial (Smit et al., 2009; Smit and Peeper,
2011). These studies suggest that TrkB has an important role in
promoting survival under conditions that trigger anoikis, and in
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inducing EMT. Additional studies that confirmi the underlying
mechanisms are required, but the current evidence that PI3K
activity is required for protection against anoikis and that MAPK
activity is required for the induction of EMT suggests that
different signaling pathways are important for the induction of
these two biological processes through TrkB. Interestingly, TrkB
has been identified as a target of the microRNA miR-200c, and a
TrkB construct that is resistant to miR200c prevents it from
inducing anoikis (Howe et al., 2011). This is an intriguing initial
observation, but further investigation is required to completely
elucidate the underlying mechanism, given that downstream
components of TrkB signalling, such as ZEB1, are also targets of
the miR200 family.
Concluding remarks
Although the molecular mechanisms that underlie anoikis and
EMT may have appeared hopelessly diverse at the inception,
unifying principles are now emerging. In particular, transcription
factors that are widespread or, quite possibly, ubiquitous
mediators (such as CTBP) or suppressors (e.g. GRHL2) of
EMT have been identified. This gives hope to the notion that
EMT can be reversed and anoikis sensitivity be restored in a
generalized fashion through drugs that target these factors. In
addition, the cell polarity complexes, which can now be viewed
as both upstream and downstream of EMT, have substantial
effects on at least three signaling pathways (Hippo, Wnt, TGF-b)
for which pharmacologically relevant compounds already exist or
are being developed. Suppression of EMT through this new
category of agents might also restore anoikis sensitivity. If this is
the case, suppression of metastasis and of disease recurrence that
is due to an EMT-related conversion of tumor cells to cancer
stem cells, could reasonably be anticipated and would constitute
a major therapeutic advance.
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